Pediatrics News

There is “wide variation” in the way clinicians measure and report the physician’s global assessment of disease activity in patients with juvenile idiopathic arthritis, according to data published in Rheumatology.

Stool culture “performed worse than would be expected” in diagnosing cholera during a period of waning cases in Haiti compared with PCR testing, according to the results of a small study.

Only one-quarter of residential addiction treatment centers caring for adolescents in the United States offer buprenorphine to patients with opioid use disorder, according to findings published Tuesday in JAMA.

The FDA has approved Linzess, the first therapy for pediatric functional constipation in patients aged 6 to 17 years, according to an agency release.

Systemic juvenile idiopathic arthritis and adult-onset Still’s disease have been combined into one entity called Still’s disease in new recommendations document presented at the EULAR 2023 Congress.

The FDA recently approved two separate vaccines to prevent respiratory syncytial virus in older adults. Soon, additional RSV prevention tools may be available for pediatric patients, too.

An FDA advisory committee on Thursday voted in favor of approving the long-acting monoclonal antibody nirsevimab to protect neonates and infants from respiratory syncytial virus.

A study found an increase in children diagnosed with anxiety during office visits in a recent 12-year period but a decrease in the proportion of office visits that included therapy, according to results published in Pediatrics.

A review of nearly 250,000 doses of messenger RNA COVID-19 vaccine administered to young children identified no serious side effects from the shots, according to results published in Pediatrics.

A new index that takes neighborhood and community conditions into consideration could be a useful measure for identifying preterm birth risk, a study published in JAMA Network Open found.